INTRODUCTION
============

Formation of ascospores by yeast cells is an unusual cell division event in which daughter cells are formed by de novo synthesis of new plasma membranes around daughter nuclei, providing an excellent model system by which to study the generation of novel intracellular membrane compartments. ([@B34], [@B35]). In response to nitrogen starvation, the fission yeast *Schizosaccharomyces pombe* exits the mitotic cell cycle, mates to form diploid cells, and enters meiosis. During meiosis II, four newly formed membrane compartments, termed forespore membranes (FSMs), appear in the cytosol ([@B42]). As meiosis is completed each of the four haploid nuclei produced by meiosis is engulfed within a forespore membrane. Capture of a nucleus and associated cytoplasm by an FSM gives rise to a nascent spore, with the forespore membrane now serving as the plasma membrane of the spore.

Real-time videomicroscopy of FSM formation in *S. pombe*, and of the analogous prospore membrane in *Saccharomyces cerevisiae*, has revealed that membrane formation can be dissected into three distinct stages: 1) membrane initiation at the spindle pole body (SPB), 2) expansion to engulf a daughter nucleus, and 3) closure to complete cytokinesis ([@B26]; [@B8]). Notably, assembly of FSMs always starts at spindle pole bodies. In yeast, spindle pole bodies, which are functional analogues of centrosomes in higher cells, have distinct nuclear and cytoplasmic faces, called the inner and outer plaques, respectively ([@B15]). In dividing cells, the inner and outer plaques serve as microtubule-organizing centers. However, at the beginning of the meiosis II, there is a protein exchange on the outer plaques, which are now called meiosis II outer plaques (MOPs) ([@B42]; [@B35]). In *S. pombe*, MOPs appear as multilayered disk-shaped structures in the electron microscope ([@B14]). The assembly of the MOP changes the function of the outer plaque from microtubule nucleation to membrane nucleation ([@B42]; [@B35]). Nascent FSMs are assembled on the outermost surface of the MOPs and the membranes remain in contact with the MOPs until very late in FSM development ([@B14]; [@B26]).

In *S. cerevisiae*, genetic and cell biological studies have demonstrated that the prospore membrane compartment is derived from the coalescence of post-Golgi secretory vesicles ([@B34], [@B35]). This is likely true for the *S. pombe* FSM as well as mutations in genes encoding soluble *N*-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins that mediate fusion at the plasma membrane in vegetative cells disrupt FSM assembly ([@B32]; [@B29]; [@B27]). In both *S. pombe* and *S. cerevisiae*, deletion of the genes for individual MOP components leads to failure of the structure to assemble and a complete block to membrane formation, indicating that the MOP is essential for vesicle coalescence ([@B19]; [@B2]; [@B36]; [@B33]). In mutants that fail to properly form MOPs, the precursor vesicles are dispersed from the spindle poles. This differentiates MOP mutants from mutants in proteins such as SNAREs that are involved directly in membrane fusion. In SNARE mutants, precursor vesicles accumulate on and around the MOP surface ([@B31]). These results, and the direct association of precursor vesicles with the MOP, suggest that the MOP functions as a vesicle tethering complex and promotes SNARE-mediated membrane fusion. How the MOP stimulates fusion of the FSM precursor vesicles is not understood.

Docking or tethering complexes function upstream of SNARE-mediated fusion in a variety of other vesicle fusion events, and often function in association with Rab GTPases ([@B38]). For example, association of secretory vesicles with the plasma membrane is mediated by a tethering complex termed the exocyst and the exocyst is an effector of the Rab GTPase ScSec4 ([@B44]; [@B13]). Rab GTPases are important regulators of vesicle traffic ([@B43a]). A Rab GTPase cycles between its guanosine triphosphate (GTP)-bound and guanosine diphosphate (GDP)-bound forms ([@B41]; [@B43a]). A Rab protein in its GTP-bound form is switched on to bind to effectors. The exchange of GDP with GTP in a Rab GTPase is facilitated by a guanine nucleotide exchange factor (GEF), and the GEF activity directs where a Rab protein executes its function ([@B18]; [@B37]; [@B5]).

In *S. cerevisiae* Sec4, the protein is activated by the GEF ScSec2. ScSec2 itself is localized to secretory vesicles, thus the GEF activity of ScSec2 serves to activate ScSec4 on the surface of the vesicles, promoting ScSec4-mediated interaction of the vesicle with the exocyst complex ([@B25]; [@B46]; [@B13]). The exchange activity of ScSec2 resides in an NH~2~-terminal coiled-coil domain (amino acids 1-160), to which ScSec4 binds ([@B46]; [@B9]). In addition to the GEF domain, the remaining 599 amino acids of the ScSec2 protein are required for its proper association with secretory vesicles ([@B10]; [@B37]). Mutants impaired in ScSec2 localization display growth defects due to a failure of polarized delivery of ScSec4-containing vesicles ([@B46]); however, overexpression of only the GEF domain is sufficient to complement the growth defect of a *sec2* deletion ([@B25]; [@B9]).

In *S. pombe*, the MOP is composed of three sporulation-specific proteins: SpSpo15, SpSpo2, and SpSpo13 ([@B33]). Localization of SpSpo13 is dependent on the other two MOP components, and SpSpo13 is thought to be located at the membrane-proximal surface of the MOP ([@B33]). Here, we report that SpSpo13 has homology to the ScSec2 GEF domain. SpSpo13 can replace the GEF domain of Scsec2 in vivo and the SpSpo13 protein can bind to ScSec4 and stimulate GDP release in vitro. A point mutation that impairs SpSpo13 GEF activity leads to a failure of FSM assembly. GDP release assays using different *S. pombe* Ypt proteins suggest that SpYpt2 is the physiological substrate of SpSpo13. These results provide the first description of a biochemical activity associated with the MOP and provide insight into how this docking complex functions to regulate the initiation of FSM formation.

MATERIALS AND METHODS
=====================

Yeast Strains Construction
--------------------------

The strains used in this study are listed in [Table 1](#T1){ref-type="table"}. HJ79 was constructed as follows. First, a *sec2*Δ heterozygous diploid, HJ75, was constructed by deleting *SEC2* in AN120 by polymerase chain reaction (PCR) ([@B21]) using pFA6a-His3MX6 as a template and HJO105 and HJO106 as primers (oligonucleotides \[oligos\] are available upon requested). Second, pRS416-*TEFpr-ScSEC2* was transformed into HJ75, and the resulting transformants were sporulated and dissected. An Ura+ His+ segregant was selected and named HJ79.

###### 

Strains used in this study

  Name                                        Genotype                                                                                                  Source
  ------------------------------------------- --------------------------------------------------------------------------------------------------------- ------------------------
  *S. cerevisiae*                                                                                                                                       
  AN120                                       *MAT*a/*MAT*α *ARG4/arg4-NspI his3SK/his3SK ho*Δ::*LYS2/ho*Δ::*LYS2 leu2/leu2*                            Neiman *et al.* (2000)
                                              *lys2/lys2RME1/rme1*Δ::*LEU2 trp1*::*hisG/trp1*::*hisG ura3/ura3*                                         
  HJ75                                        *MAT*a/*MAT*α *ARG4/arg4-NspI his3SK/his3SK ho*::*LYS2/ho*::*LYS2 leu2/leu2*                              This study
                                              *lys2/lys2RME1/rme1*::*LEU2 trp1*::*hisG/trp1*::*hisG ura3/ura3 sec2*Δ*his5*+/*SEC2*                      
  HJ79                                        *MAT*a *arg4-NspI his3SK ho*::*LYS2 leu2 lys2 rme1*::*LEU2 trp1*::*hisG ura3 sec2*Δ*his5*+                This study
  HJ75-4                                      *MAT*α *arg4-NspI his3SK ho*::*LYS2 leu2 lys2 RME1 trp1*::*hisG ura3 sec2*Δ*his5*+pRS416-*TEFpr-ScSEC2*   This study
  *S. pombe*                                                                                                                                            
  GP46                                        *h*+ *ade6-M375 ura4-294*                                                                                 [@B45]
  B82                                         *h90 spo13-B82 ade6-M210*                                                                                 [@B4]
  ANP3                                        *h90 spo13-B82 ura4-294*                                                                                  This study
  GP1327                                      *h90 ade6-52 ura4-294 leu1-32*                                                                            [@B20]
  HJP1                                        *h90 spo13-B82 ura4-294 leu1-32*                                                                          This study
  FY12476[^a^](#TF1-1){ref-type="table-fn"}   *h90 spo13::ura4*^+^*ura4 leu1 sid4GFP::kanR*                                                             

^a^ This strain was obtained from the Yeast Genetic Resource Center of Japan supported by the National Bioresource Project (YGRC/NBRP) (<http://yeast.lab.nig.ac.jp/nig/>).

ANP3 is an *S. pombe* segregant from a cross between GP46 (a gift from Gerry Smith, Fred Hutchinson Cancer Research Center, Seattle, WA) and B82 (a gift from Chikashi Shimoda, Osaka City University, Osaka, Japan). HJP1 was obtained as a segregant from a cross of ANP3 and GP1327 (a gift from Gerry Smith).

Plasmids
--------

The plasmids used in this study are listed in [Table 2](#T2){ref-type="table"}. To make plasmids pRS416TEF-*ScSEC2* and pRS414TEF-*ScSEC2*, full-length *ScSEC2* was amplified by PCR using *S. cerevisiae* genomic DNA from strain AN120 as a template and HJO97 and HJO98 as primers (sequences of all primers used are available upon request). The PCR products were purified, digested with EcoRI and XhoI, and cloned into similarly digested pRS416TEF or pRS414TEF ([@B24]). *ScSEC2^1-160^* and *ScSEC2^161-759^* were similarly amplified by PCR from strain AN120 using oligos HJO97 and HJO99, and HJO104 and HJO98, respectively. The EcoRI- and XhoI-digested PCR products were cloned into similarly digested pRS414TEF to get pRS414TEF-*ScSEC2^1-160^* and pRS414TEF-*ScSEC2^161-759^*.

###### 

Plasmids used in this study

  Plasmid                                                          Selected features      Source
  ---------------------------------------------------------------- ---------------------- ---------------
  pRS416TEF                                                        *CEN, ARSH4, URA3*     [@B24]
  pRS414TEF                                                        *CEN, ARSH4, TRP1*     [@B24]
  pRS416TEF-*ScSEC2*                                               *CEN, ARSH4, URA3*     This study
  pRS414TEF-*ScSEC2*                                               *CEN, ARSH4, TRP1*     This study
  pRS414TEF-*ScSEC2^1-160^*                                        *CEN, ARSH4, TRP1*     This study
  pRS414TEF-*ScSEC2^161-759^*                                      *CEN, ARSH4, TRP1*     This study
  pRS414TEF-*Spspo13*^+^                                           *CEN, ARSH4, TRP1*     This study
  pRS414TEF-*Spspo13*^+^-*ScSEC2^161-759^*                         *CEN, ARSH4, TRP1*     This study
  pRS425TEF-*Spypt2*^+^                                            *2 micron, LEU2*       This study
  pGP564-*ScSEC4*                                                  *2 micron, LEU2*       [@B16]
  pGP564-*ScYPT1*                                                  *2 micron, LEU2*       [@B16]
  pGP564-*ScYPT31*                                                 *2 micron, LEU2*       [@B16]
  pJRU-MCS2                                                        YRp, *ars1, ura4*^+^   [@B23]
  pJRU-MCS2-P*~SpSpo13~-Spspo13*^+^                                YRp, *ars1, ura4*^+^   This study
  pJRU-MCS2-P*~SpSpo13~-Spspo13-F79A*                              YRp, *ars1, ura4*^+^   This study
  pJRU-MCS2-P*~SpSpo13~-Spspo13*^+^-mRFP                           YRp, *ars1, ura4*^+^   This study
  pJRU-MCS2-P*~SpSpo13~-Spspo13-F79A* -mRFP                        YRp, *ars1, ura4*^+^   This study
  FY532[^a^](#TF2-1){ref-type="table-fn"} (pREP41-GFP-*psy1*^+^)   YRp, *ars1, LEU2*      [@B28]
  pET15b                                                           His-tag, Amp^R^        Novagen
  pET15b-*ScSEC4*                                                  His-tag, Amp^R^        This study
  pET15b-*ScYPT1*                                                  His-tag, Amp^R^        This study
  pET15b-*Spypt1*^+^                                               His-tag, Amp^R^        This study
  pET15b-*Spypt2*^+^                                               His-tag, Amp^R^        This study
  pET15b-*Spypt3*^+^                                               His-tag, Amp^R^        This study
  pGEX5X-1                                                         GST, Amp^R^            GE Healthcare
  pGEX5X-1-*ScSEC2^1-160^*                                         GST, Amp^R^            This study
  pGEX3X-*Spspo13*^+^                                              GST, Amp^R^            This study
  pGEX3X-*Spspo13-F79A*                                            GST, Amp^R^            This study

^a^ This plasmid was obtained from the Yeast Genetic Resource Center of Japan supported by the National Bioresource Project (YGRC/NBRP) (<http://yeast.lab.nig.ac.jp/nig/>).

The *Spspo13*^+^ coding region was amplified by PCR using *S. pombe* genomic DNA as a template and HJO116 and HJO134 as oligos. Because the genomic DNA of *Spspo13*^+^ contains an intron after the fifth codon, HJO116 was designed to add these codons to the 5′ end second exon and thereby remove the intron. The *Spspo13*^+^ coding region was then digested with EcoRI and XhoI, and cloned into similarly digested pRS414TEF to get pRS414TEF-*Spspo13*^+^.

To construct the chimeric plasmid, pRS414TEF-*Spspo13*^+^-*ScSEC2^161-759^*, the coding region of *Spspo13*^+^, without the stop codon, was PCR amplified from *S. pombe* genomic DNA using HJO116 and HJO117 as oligos. A BamHI-EcoRI--digested PCR fragment was then cloned into similarly digested pRS414TEF-*ScSEC2^161-759^*.

Plasmid pJRU-MCS2 ([@B23]) was used as the vector backbone for plasmids used in *S. pombe*. The *Spspo13*^+^ promoter (−500 upstream of first ATG) was amplified from *S. pombe* genomic DNA by oligos HJO178 and HJO179. The PCR products was purified, digested with XhoI and PstI, and cloned into similarly digested pJRU-MCS2 to create pJRU-MCS2-P~*SpSpo13*~. To make pJRU-MCS2-P*~SpSpo13~-Spspo13*^+^, the *Spspo13*^+^ coding region was PCR amplified using *S. pombe* genomic DNA as a template and HJO176 and HJO145 as oligos. A KpnI-SacI--digested PCR fragment was cloned into similarly digested pJRU-MCS2-P~*SpSpo13*~.

The plasmid pJRU-MCS2-P*~SpSpo13~-Spspo13*^+^-mRFP was constructed in three steps. First, a PCR fragment containing the monomeric red fluorescent protein (mRFP) gene was amplified using pTi mRFP as a template ([@B11a]) and YSO33 and HNO944 as primers and cloned as a HindIII-XhoI fragment into pRS424*TEF* ([@B24]). Next, the mRFP fragment from this construct was isolated as an EcoRI-XhoI fragment and used to replace the *ScSEC2* coding region of pRS414TEF-*Spspo13*^+^-*ScSEC2^161-759^*, creating pRS414TEF-*Spspo13*^+^-*mRFP*. Finally, *Spspo13-mRFP* was PCR amplified from pRS414TEF-*Spspo13*^+^-mRFP by using HJO176 and HJO188 as oligos. This PCR product was KpnI-SacI digested and cloned into pJRU-MCS2-P~*SpSpo13*~.

pJRU-MCS2-*SpSpo13pr-Spspo13-F79A* was created by site-directed mutagenesis of the plasmid pJRU-MCS2-*SpSpo13pr-Spspo13*^+^ using oligos HJO182 and HJO183 (QuikChange kit; Stratagene, La Jolla, CA). The same oligos were used for site-directed mutagenesis of pJRU-MCS2-*SpSpo13pr-Spspo13*^+^-mRFP to make pJRU-MCS2-*SpSpo13pr-Spspo13-F79A*-mRFP. The *Spspo13* gene was fully sequenced after mutagenesis to ensure that no other mutations were introduced during the procedure (sequencing performed at the Stony Brook DNA Sequencing Facility).

To construct plasmids expressing 6XHis-tagged *ScSEC4* or *ScYPT1*, *ScSEC4* and *ScYPT1* were PCR amplified using *S. cerevisiae* genomic DNA as a template and using oligos HJO150 and HJO151, HJO152 and HJO153, respectively. The PCR products were purified, digested with XhoI and BamHI, and cloned into similarly digested plasmid pET15b (Novagen, Madison, WI) To make plasmids expressing glutathione transferase (GST)-tagged *ScSEC2^1-160^*, an EcoRI-XhoI fragment of pRS414-*TEFpr-ScSEC2^1-160^* containing Sc*SEC2^1-160^* was cloned into pGEX5X-1 (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom). To make plasmids expressing GST-tagged *Spspo13*^+^, the *Spspo13*^+^ gene was first PCR amplified using pRS414-*TEFpr-Spspo13*^+^ as a template and HJO137 and HJO134 as oligos. The PCR product was then cloned into pGEX3X (GE Healthcare) as a BamHI-EcoRI fragment. The plasmid expressing GST-tagged *Spspo13-F79A* was constructed by site-directed mutagenesis of the plasmid pGEX3X-*Spspo13*^+^ using oligos HJO182 and HJO183.

S. pombe Sporulation Assays
---------------------------

Freshly transformed *S. pombe* cells were grown on selective medium at 32°C for 2 d. The cells were then patched onto an SPA plate (1%, wt/vol glucose, 7.3 mM KH~2~PO~4~, 1 ml of 1000× vitamin stock, and 3%, wt/vol Difco Bacto Agar \[Difco, Detroit, MI\]) to induce mating and sporulation. Sporulation was assayed by observation in the light microscope after 15--18 h incubation on the SPA plate at room temperature.

Fluorescence Microscopy
-----------------------

Freshly transformed *S. pombe* cells were cultured in 3 ml of EMM2 (3 g/l potassium hydrogen phthalate, 2.2 g/l sodium phosphate dibasic, 5 g/l ammonium chloride, 20 g/l dextrose, 2.1 g/l minimal salts, 0.2 g/l vitamins, and 3 mg/l trace elements), with selective supplements (75 μg/ml adenine and 225 μg/ml histidine) for 24 h. The cells were precipitated, washed twice with 1 ml EMM-N sporulation medium (3 g/l potassium hydrogen phthalate, 2.2 g/l sodium phosphate dibasic, 20 g/l dextrose, 2.1 g/l minimals, 0.2 g/l vitamins, and 3 mg/l trace elements). The cells were induced to enter meiosis by incubating in 3 ml of EMM-N at room temperature. After 9-h incubation in the EMM-N, aliquots of cells were examined in an Axioplane2 microscope (Carl Zeiss, Thornwood, NY). Fluorescence images were obtained by using Axiovision release 4.7.

Recombinant Protein Preparation
-------------------------------

All recombinant proteins were expressed in Escherichia coli (*BL21*) and induced at room temperature by adding 0.5 mM isopropyl β-d-thiogalactoside for 4 h. The 6XHis-tagged Rab proteins were purified using nickel-nitrilotriacetic acid Superflow columns under native conditions (QIAGEN, Valencia, CA). To stabilize nucleotide-binding protein, 0.1 mM GDP was included in the lysis buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 10 mM imidazole, pH 8.0), wash buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, 20 mM imidazole, pH 8.0) and elution buffer (50 mM NaH~2~PO~4~, 300 mM NaCl, and 250 mM imidazole, pH 8.0). After elution, samples were concentrated by centrifugation in a Microcon YM-10 centrifugal filter unit (Millipore, Billerica, MA) and kept in storage buffer (20 mM Tris, pH 8.0, 100 mM KCl, 1 mM dithiothreitol \[DTT\], 0.1 mM GDP, 100 μM phenylmethylsulfonyl fluoride \[PMSF\], and 20% glycerol) at −20°C.

GST fusion proteins were purified as described previously ([@B30]). After elution and concentration, samples were kept in storage buffer (20 mM Tris, pH 8.0, 100 μM PMSF, and 20% glycerol) at −20°C.

GST Pull-Down Assay
-------------------

GST pull-down assays were modified from [@B37]. For binding experiments with the nucleotide-bound form of Rab proteins, 0.8 μg of 6XHis-ScSec4 or 6XHis-ScYpt1 was preloaded with GDP or guanosine 5′-(β,γ-imido)triphosphate (GppNHp) in MgCl~2~ binding buffer (1× phosphate-buffered saline \[PBS\], 5 mM MgCl~2~, 1 mg/ml bovine serum albumin \[BSA\], and 1 mM DTT) for 30 min at room temperature. The GST fusion proteins immobilized on glutathione-Sepharose beads (30 μl of beads) were incubated with the preloaded Rab proteins (0.3 μg) in the MgCl~2~ binding buffer for 60 min at room temperature. After the binding reactions, the glutathione-Sepharose beads were washed five times with PBS buffer containing MgCl~2~ and resuspended in 2× SDS sample buffer (60 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 0.05 mg/ml bromphenol blue, and 5% β-mercaptoethanol). Pull-down products were separated by SDS-polyacrylamide gel electrophoresis and analyzed by Western blot. 6XHis-ScSec4 and 6XHis-ScYpt1 were first detected by rabbit anti-histidine antibody (Santa Cruz Biotechnology, Santa Cruz, CA), and then goat anti-rabbit peroxidase-conjugated secondary antibody was used (GE Healthcare). GST fusion proteins were detected by goat horseradish peroxidase-conjugated anti-GST antibody (Abcam, Cambridge, MA).

For binding experiments with the nucleotide-free form of the Rab proteins, 6XHis-ScSec4 and 6XHis-ScYpt1 were not preloaded with nucleotides but were incubated with GST fusion proteins immobilized on beads in EDTA binding buffer (1× PBS, 5 mM EDTA, 1 mg/ml BSA, and 1 mM DTT). The resins were washed with PBS buffer containing EDTA.

Nucleotide Exchange Assays
--------------------------

Purified 6XHis-tagged Rab proteins were incubated in loading buffer (50 mM Tris, pH 8.0, 100 mM KCl, 1 mM EDTA, and 1 mM DTT) containing a twofold molar excess of GDP (Jena Bioscience, Jena, Germany) or *N*-methylanthraniloyl (mant)-GDP (Invitrogen, Carlsbad, CA) for 30 min at room temperature. To terminate the loading reaction, MgCl~2~ was added to a final concentration of 20 mM, and free GDP or free mant-GDP was removed by centrifugation in a Microcon YM-10 filter unit (Millipore). 6XHis-Rab bound to GDP or mant-GDP was then concentrated in buffers containing 50 mM Tris, pH 8.0, 100 mM KCl, and 6 mM MgCl~2~.

For the GTP loading assay, 100 nM mant-GppNHp (Invitrogen) was added to reaction buffer (10% glycerol, 50 μg/ml BSA, 50 mM Tris, pH 8.0, 100 mM KCl, 1 mM DTT, and 6 mM MgCl~2~) and allowed to equilibrate for 300 s in a thermostated cuvette (15°C). To initiate the reaction, 6XHis-ScSec4 preloaded with GDP was added to the mixture to a final concentration of 400 nM. To test GEF activity, purified GST, GST-ScSec2, or GST-SpSpo13 was premixed with 6XHis-ScSec4-GDP and then added to the mixture at the concentrations indicated. Fluorescence emission was monitored every 5 s for a total of 1500 s by using a fluorimeter (FP-6200; Jasco, Tokyo, Japan) with the following settings: λ~ex~ = 290 nm, λ~em~ = 460 nm, and slits = 5/5.

For GDP release assay, 6XHis-ScSec4 was loaded with mant-GDP as describe above and added to the reaction buffer containing an excess of GppNHp (final concentration, 20 μM) (Jena Bioscience). The dissociation of mant-GDP was first monitored without a GEF protein by using the fluorimeter with the same settings as described in GTP loading studies. At the indicated time point, purified GST-ScSec2, GST-SpSpo13, or GST-SpSpo13^F79A^, or EDTA, was added to the mixture at desired concentrations, and the fluorescence emission was then monitored for another 1300 s.

RESULTS
=======

The MOP Component SpSpo13 Has Homology to ScSec2 GEF Domain
-----------------------------------------------------------

*Spspo13*^+^ encodes a protein of 138 amino acids predicted to form a coiled-coil structure ([@B33]). Iterative blast searches with the full-length SpSpo13 revealed a strong patch of conservation between SpSpo13 and the ScSec2 protein of budding yeast. Full-length SpSpo13 shares 24% identity and 43% similarity with the N-terminal 160 amino acids that contain the GEF activity of ScSec2 ([Figure 1](#F1){ref-type="fig"}). The crystal structure of this domain of ScSec2 has been solved in complex with ScSec4 ([@B9]; [@B40]). The residues of ScSec2 that contact ScSec4 are highly conserved in SpSpo13 ([Figure 1](#F1){ref-type="fig"}). This sequence homology suggests that SpSpo13 might have GEF activity similar to ScSec2.

![SpSpo13 is homologous to the ScSec2 GEF domain. (A) Sequence alignment of ScSec2 GEF domain with SpSpo13. Identical residues are highlighted in yellow, and conservative changes are shaded gray. ScSec2 residues that are found in a close contact with ScSec4 in the cocrystal structure are in red ([@B9]). Spspo13 residues that are conserved in the ScSec4 binding surface are in green. Phe79 of SpSpo13 that was mutated to alanine is indicated in green. (B) View of the cocrystal structure of ScSec2 GEF domain and ScSec4 (PDB [2OCY](2OCY); [@B9]). ScSec4 is in gray, above and the ScSec2 dimer is below. The switch I and II regions of ScSec4 are labeled. The side chains of the ScSec2 residues highlighted in A are shown in red, except for Phe109 in green.](zmk0071094010001){#F1}

SpSpo13^+^ Can Substitute for the ScSEC2 GEF Domain
---------------------------------------------------

If SpSpo13 has GEF activity, it might be able to substitute for ScSec2 in activating ScSec4 in *S. cerevisiae*. Sc*SEC2* is an essential gene in budding yeast ([@B25]). The N-terminal GEF domain is sufficient to support the essential function of ScSec2, and the remaining C-terminal region seems to be required for proper polarized localization of ScSec2 ([@B10]; [@B37]). To examine whether *SpSpo13*^+^ can provide GEF function, *Spspo13*^+^/ *ScSEC2* chimeras were constructed and tested for ability to rescue the growth of a *sec2*Δ strain.

Using a plasmid shuffle approach, we showed that the *ScSEC2* GEF domain alone (*ScSEC2^1-160^*) was sufficient to restore the growth of the *sec2*Δ mutant at a level comparable with expression of full-length *ScSEC2* gene, in agreement with an earlier report ([@B37]). In contrast, the *ScSEC2* C-terminal region (*ScSEC2^161-759^*) failed to rescue the growth defect of the *sec2*Δ mutant ([Figure 2](#F2){ref-type="fig"}).

![A *Spspo13*^+^-*ScSec2* chimera rescues the growth defect of a *sec2*Δ. Strain HJ79 (*sec2*Δ; *pCEN-URA3-ScSEC2*) was transformed with *CEN-TRP1*-plasmids carrying the indicated genes. Numbers indicate amino acids. The transformed strains were grown in nonselective media overnight, and 10-fold serial dilutions of the overnight culture were spotted onto a synthetic plate lacking tryptophan and uracil or onto a plate containing 5-fluoroorotic acid (5-FOA). The plates were photographed after 2-d incubation at 30°C.](zmk0071094010002){#F2}

Although *Spspo13*^+^ alone did not suppress the *sec2*Δ growth defect, the *Spspo13*^+^-*ScSEC2^161-759^* fusion did restore growth ([Figure 2](#F2){ref-type="fig"}), indicating that this fusion gene encodes a functional protein that can substitute for ScSec2. This result indicates that SpSpo13 has GEF activity capable of activating ScSec4 in *S. cerevisiae*.

SpSpo13 Binds Preferentially to the Nucleotide-free Form of ScSec4
------------------------------------------------------------------

To test directly whether SpSpo13 can bind to ScSec4, glutathione transferase-tagged-SpSpo13 (GST-SpSpo13) was prepared from E. coli. The predicted molecular mass of the GST-SpSpo13 fusion protein is ∼44 kDa, and a band that ran a little above the 37-kDa marker was confirmed as GST-SpSpo13 by Western blot analysis using anti-GST antibodies ([Figure 3](#F3){ref-type="fig"}A). GEFs preferentially bind to the nucleotide-free form of their target GTPase ([@B3]). GST-SpSpo13 attached to glutathione-Sepharose beads was therefore incubated with three different forms of recombinant hexahistidine-tagged ScSec4 (6XHis-ScSec4): the GDP-bound form, GppNHp (a nonhydrolysable analogue of GTP)-bound form, or the nucleotide-free form. Binding of ScSec2 GEF domain GST-ScSec2^1-160^ was performed as a positive control in the binding assay.

![SpSpo13 binds preferentially to the nucleotide free form of ScSec4. GST-pull down assays. (A) 6XHis-ScSec4 bound to GppNHp (Gp.), GDP, or in its nucleotide-free (n.f.) form was mixed with the indicated GST fusion. After precipitation of the GST fusion proteins, the resulting pellets were analyzed by Western blot using anti-6XHis antibodies to detect precipitated 6XHis-ScSec4 (top) or with anti-GST antibodies to detect SpSpo13 and ScSec2^1-160^. (B) GST-SpSpo13 immobilized on Sepharose beads was mixed with different derivatives of 6XHis-ScYpt1 or 6XHis-ScSec4 and analyzed as described in A. Input (right) represents 10% of Rab proteins used per binding reaction.](zmk0071094010003){#F3}

GST-SpSpo13 preferentially bound to the nucleotide-free form of ScSec4 compared with the GDP- or GppNHp-bound form, whereas GST-ScSec2^1-160^ displayed binding to both the GDP-bound and nucleotide-free forms. The interaction of GST-SpSpo13 and ScSec4 was specific because GST alone did not bind to any conformations of ScSec4, and GST-SpSpo13 did not bind to another Rab GTPase, ScYpt1 ([Figure 3](#F3){ref-type="fig"}B). These binding characteristics of GST-SpSpo13 support the idea that SpSpo13 is a guanine nucleotide exchange protein.

SpSpo13 Has Guanine Nucleotide Exchange Activity toward ScSec4 In Vitro
-----------------------------------------------------------------------

To confirm that SpSpo13 can act as a GEF, a real time fluorescent nucleotide exchange assay that monitored the level of ScSec4 activation was performed ([@B39]). In this assay, ScSec4 was preloaded with GDP and added to buffer containing a limited amount of mant-GppNHp. Binding of the mant-GppNHp, a fluorescent nonhydrolysable analogue of GTP, to ScSec4 is detected by monitoring a fluorescence resonance energy transfer (FRET) interaction between a tryptophan residue on ScSec4 and the fluorophore. Although little FRET was detected with buffer containing only the fluorophore, an increase of fluorescence intensity was observed when ScSec4-GDP alone was added ([Figure 4](#F4){ref-type="fig"}A). The fluorescence intensity increased linearly over the time course after ScSec4 was added, probably due to the high intrinsic GDP-release rate of ScSec4 ([@B37]). Notably, when ScSec4 was premixed with GST- SpSpo13 and added to the buffer containing mant-GppNHp, the increase in fluorescence intensity during first 200 s was dramatically higher, and the fluorescence intensity soon reached an asymptotic value ([Figure 4](#F4){ref-type="fig"}A). Similar results were seen when ScSec4 was premixed with the known GEF, GST-ScSec2^1-160^ ([Figure 4](#F4){ref-type="fig"}A). In contrast, the initial rate of ScSec4 activation did not rapidly increase when ScSec4 premixed with GST.

![SpSpo13 facilitates nucleotide exchange on ScSec4. (A) SpSpo13 stimulates GTP binding. ScSec4 was preloaded with GDP. At t = 300 s (indicated by arrow), ScSec4 alone, ScSec4 mixed with GST, ScSec4 mixed with GST-ScSec2^1-160^, or ScSec4 mixed with GST-SpSpo13 was added to buffer containing the fluorescent GTP analogue mant-GppNHp. We used 400 nM ScSec4-GDP per reaction. Binding of the analogue to ScSec4 was monitored by following the fluorescence signal created by a FRET interaction between ScSec4 and the mant-GppNHp. The gray line indicates the basal level of fluorescence signal from the fluorophore under these conditions. (B) SpSpo13 stimulates GDP release. 6XHis-ScSec4 preloaded with the fluorescent GDP analogue mant-GDP was incubated in buffer containing GppNHp. We used 400 nM ScSec4-mant-GDP per reaction. At the time indicated by the arrow, buffer, GST-ScSec2^1-160^, or GST-SpSpo13 was added to the reaction mixture. Release of GDP was monitored by a loss of fluorescent signal from the ScSec4-mant-GDP FRET interaction. The gray line indicates the basal level of fluorescence signal from the fluorophore under these conditions.](zmk0071094010004){#F4}

This assay establishes that SpSpo13 can stimulate GTP binding by ScSec4 but, because of the low concentration of mant-GppNHp present in the buffer, is not informative about the kinetics of GDP release ([@B39]). To examine these kinetics, the displacement of mant-GDP from ScSec4 in a solution containing a large excess of GppNHp was examined. In the reverse of the mant-GppNHp loading assay, release of mant-GDP from ScSec4 was monitored by a decrease of FRET ([Figure 4](#F4){ref-type="fig"}B). Addition of GST-ScSec2^1-160^ to buffer containing the mant-GDP loaded ScSec4 triggered a swift drop of fluorescence intensity to a basal level, indicating that GST-ScSec2^1-160^ efficiently facilitates mant-GDP dissociation. Addition of GST-SpSpo13 to the preloaded ScSec4 also stimulated a drop in fluorescence intensity but at a much slower rate ([Figure 4](#F4){ref-type="fig"}B), indicating that SpSpo13 facilitates mant-GDP release of ScSec4 with slower kinetics than GST-ScSec2^1-160^. These data demonstrate that SpSpo13 can act as a GEF for ScSec4 in vitro, though not as efficiently as its natural GEF, ScSec2. This result is consistent with our finding that *Spspo13*^+^-*ScSEC2^161-759^* rescues the growth of a *sec2*Δ mutant less well than the native *ScSEC2* in vivo ([Figure 2](#F2){ref-type="fig"}).

A Mutation in Spspo13 That Impairs GEF Activity Blocks FSM Formation
--------------------------------------------------------------------

Within the ScSec4 binding site of ScSec2, Phe109 of ScSec2 is a critical residue for its GEF activity and binding affinity for ScSec4 ([@B40]; [Figure 1](#F1){ref-type="fig"}). We reasoned that if SpSpo13 acts on an *S. pombe* Rab in a similar way to ScSec2 on ScSec4, then the corresponding residue of SpSpo13, Phe79, should be essential for SpSpo13 GEF activity. Therefore, Phe79 of SpSpo13 was mutated to alanine, and the resulting mutant protein was tested in the GST-pull-down and GEF assays. The pull-down assay revealed that GST-SpSpo13^F79A^ still bound to the nucleotide-free form of ScSec4 but at a lower level than wild-type GST-SpSpo13 ([Figure 5](#F5){ref-type="fig"}A). In the GEF assay, adding GST-SpSpo13^F79A^ did not stimulate mant-GDP dissociation, indicating that the mutant protein has lost GEF activity in vitro ([Figure 5](#F5){ref-type="fig"}B). Moreover, expression of a *Spspo13-F79A-ScSEC2^161-759^* fusion gene in a *sec2*Δ mutant does not support cell growth in *S. cerevisiae* (data not shown), suggesting that the mutant protein lacks GEF activity in vivo as well.

![Mutation of conserved residue in SpSpo13 leads to the loss of GEF activity in vitro and a FSM assembly defect in vivo. (A) GST-SpSpo13 displays reduced binding to ScSec4. GST-SpSpo13 or GST-SpSpo13^F79A^ immobilized on glutathione-Sepharose beads was mixed with the nucleotide-free (n.f.), GDP-bound, or GppNHp-bound (Gp.) forms of 6XHis-ScSec4. The mixtures were centrifuged, and the resulting pellets analyzed by Western blot. Top, blot probed with anti-6XHis antibodies. Bottom, same samples probed with anti-GST antibodies. (B) GDP release assay. 6XHis-ScSec4 preloaded with the fluorescent GDP analogue mant-GDP was incubated in buffer containing GppNHp. At the time indicated by the arrow, buffer (yellow line), 400 nm GST-SpSpo13 (red line), or 800 nM GST-SpSpo13^F79A^ (blue line) was added to the reaction mixture. Release of GDP was monitored by a loss of fluorescent signal from the ScSec4-mant-GDP FRET interaction.](zmk0071094010005){#F5}

To examine the effect of the F79A mutant on sporulation and FSM formation in *S. pombe*, plasmids carrying *Spspo13*^+^ or *Spspo13-F79A* were expressed in a *spo13-B82* mutant. The *spo13-B82* allele has a nonsense mutation at the 53rd residue and fails to form FSMs or spores ([@B33]) Introduction of the wild-type *Spspo13*^+^ restored sporulation to this strain; however expression of *Spspo13-F79A* did not ([Figure 6](#F6){ref-type="fig"}A). SpSpo13 and SpSpo13^F79A^ were next tagged with mRFP and expressed in sporulating cells under the native *spo13* promoter. Sid4-GFP was used as a marker for the SPB ([@B6]). Spo13-mRFP was visible at the SPB, beginning with cells in meiosis I and persisted at the SPB throughout meiosis II, as reported previously ([@B33]; [Figure 6](#F6){ref-type="fig"}B). The localization of SpSpo13^F79A^-mRFP was indistinguishable from the wild-type protein ([Figure 6](#F6){ref-type="fig"}C), indicating that the mutant protein is expressed and properly localized. To more closely examine the *Spspo13-F79A* defect, FSM assembly was visualized using GFP-Psy1, which encodes a SNARE protein and localizes at FSM during meiosis II ([@B22]), and SpSpo13 was detected again by tagging with mRFP. Growing FSMs were observed adjacent to each of the SPBs in 100% of the cells expressing wild-type *Spspo13*^+^ (n = 20), but no FSMs were formed in cells expressing *Spspo13-F79A* ([Figure 7](#F7){ref-type="fig"}) (n = 20). The GEF activity of SpSpo13 is therefore required for FSM assembly in *S. pombe*.

![SpSpo13^F79A^ fails to support spore formation but localizes properly to the SPB. (A) *spo13-F79A* cells fail to sporulate. Strain ANP3 (*h90*, *spo13-B82*) was transformed with plasmids carrying *Spspo13*^+^ or *Spspo13-F79A* and incubated on sporulation medium. Sporulation was assessed by light microscopy. The sporulation frequency for each strain, measured as the percentages of asci out of 200 total zygotes, is shown. (B and C) SpSpo13^F79A^-mRFP and SpSpo13-mRFP localize to the meiotic SPB. Strain FY12476 (*h90 spo13::ura4*^+^ *ura4 leu1 sid4GFP::kanR*) was transformed with plasmids carrying *Spspo13*^+^-mRFP or SpSpo13^F79A^-mRFP, sporulated, and examined by fluorescence microscopy.](zmk0071094010006){#F6}

![Loss of GEF activity in SpSpo13 leads to an FSM assembly defect in vivo. *Spspo13^F79A^* cells do not form FSMs. Strain HJP1 (*h90*, *spo13-B82*) was cotransformed with plasmids carrying GFP-Psy1 and *Spspo13*^+^-mRFP or *Spspo13^F79A^*-mRFP, sporulated, and examined by fluorescence microscopy. Arrows indicate FSMs.](zmk0071094010007){#F7}

SpYpt2 Is the Probable In Vivo Target of Spspo13
------------------------------------------------

SpYpt2 is the *S. pombe* Rab most closely related to ScSec4 and, like ScSec4 has been shown to function in exocytosis ([@B7]). Given the homology of ScSec4 and SpYpt2, the activity of SpSpo13 on ScSec4, and that ScSec4 has been shown to be required for prospore membrane formation during sporulation in *S. cerevisiae* ([@B34]), SpYpt2 is a strong candidate to be the physiological target of SpSpo13. A 6XHis-tagged version of SpYpt2 was purified from E. coli, and the ability of SpSpo13 to stimulate GDP release was examined ([Figure 8](#F8){ref-type="fig"}A). Similar to what was observed with ScSec4 as a substrate ([Figure 4](#F4){ref-type="fig"}B), SpSpo13 stimulated GDP release, although not as efficiently as ScSec2. Thus, SpSpo13 can act on SpYpt2. To examine the specificity of SpSpo13, two other *S. pombe* Rab proteins, SpYpt1 and SpYpt3, were also purified and examined. Addition of 6 mM EDTA to the reaction was used as a control for GDP release in these experiments ([Figure 8](#F8){ref-type="fig"}B). SpSpo13 failed to stimulate release of GDP from either SpYpt1 or SpYpt3, indicating specificity of SpYpt2 in vitro.

![SpSpo13 specifically facilitates nucleotide exchange by SpYpt2. (A) SpSpo13 stimulates GDP release by SpYpt2. 400 nM SpYpt2-mant-GDP was used per reaction. At the time point indicated by the arrow, GST-ScSec2^1-160^ or GST-SpSpo13 was added to the reaction mixture at the indicated concentrations. (B) SpSpo13 cannot stimulate GDP release by SpYpt1 or SpYpt3. We used 400 nM SpYpt1-mant-GDP or 400 nM SpYpt3 per reaction. At the time point indicated by the arrow, 400 nM GST-SpSpo13 or 6 mM EDTA was added to the reaction mixture. (C) SpSpo13 genetically interacts with SpYpt2 in vivo. Strain HJ75-4 (*sec2*Δ; *pCEN-URA3-ScSEC2*) was cotransformed with a *CEN-TRP1*-plasmid carrying Spspo13^+^ and *2*μ-*LEU2*-plasmids carrying indicated *YPT* genes. The transformed strains were grown in nonselective media overnight, and 10-fold serial dilutions of the overnight culture were spotted onto a synthetic plate lacking tryptophan and leucine or onto a plate containing 5-fluoroorotic acid (5-FOA). The plates were photographed after 2-d incubation at 30°C.](zmk0071094010008){#F8}

Deletion of SpYpt2 is lethal ([@B7]), and overexpression of SpYpt2 did not rescue the spore formation defect of the *spo13-F79A* mutant (Yang, unpublished observations). Therefore, to look for evidence of in vivo interaction between SpSpo13 and SpYpt2, we used the *sec2*Δ rescue assay. SpSpo13 expression was unable to rescue the growth defect of a *sec2*Δ mutant ([Figure 2](#F2){ref-type="fig"}). Similarly, overexpression of ScSec4, ScYpt1, SpYpt2, or ScYpt31 did not restore growth to the mutant. However, coexpression of SpSpo13 with SpYpt2 or with ScSec4 allowed rescue of the *sec2*Δ mutant ([Figure 8](#F8){ref-type="fig"}C). In particular, coexpression of SpSpo13 and SpYpt2 completely rescued the growth defect. This result indicates that SpSpo13 can interact with SpYpt2 in vivo as well as in vitro.

DISCUSSION
==========

We report here that a SPB component in *S. pombe*, SpSpo13, has homology to the GEF domain of ScSec2 and can function to stimulate nucleotide exchange both in vitro and in vivo. A mutation of SpSpo13 that impairs GEF activity blocks FSM assembly, indicating that the GEF activity is required for MOP-mediated membrane formation. Several lines of evidence suggest that SpYpt2 is the physiological Rab target of SpSpo13: 1) SpYpt2 is the homologue of ScSec4, which is required for prospore membrane formation in *S. cerevisiae* ([@B34]); 2) SpSpo13 can act as a GEF for ScSec4 both in vivo and in vitro and 3) interact with SpYpt2 when coexpressed in *S. cerevisiae*; and 4) SpSpo13 specifically stimulates GDP release from SpYpt2 and not other *S. pombe* Rab proteins in vitro.

In *S. cerevisiae*, vesicles attach to the MOP before fusion ([@B31]), suggesting that the MOP functions as a vesicle docking complex upstream of SNARE-mediated membrane fusion. In this light, our finding that the *S. pombe* MOP contains a GEF activity provides a strong parallel to other vesicle tethering complexes ([@B43a]). For example, the TRAPP-I and TRAPP-II complexes involved in endoplasmic reticulum-to-Golgi trafficking and intra-Golgi trafficking, contain GEF activity directed toward Ypt1, and possibly Ypt31/Ypt32 ([@B17]; [@B5]). Similarly, the Vps-C/HOPS complex involved in endosome--vacuole trafficking acts as a Ypt7-directed GEF ([@B48]). Stimulation of Rab activity may be a common mechanism by which tethering complexes promote the downstream events of vesicle fusion.

The fact that SpSpo13 is a component of the SPB also highlights a difference between the function of SpSpo13 and ScSec2. In addition to the GEF domain, ScSec2 has additional domains that target it to the vesicle and interact with the exocyst complex ([@B10]; [@B37]). ScSec2 is therefore thought to associate with transport vesicles and travel with them to the site of membrane fusion ([@B46]). By contrast, SpSpo13 is already localized to the future site of membrane fusion, the SPB, in meiosis I before precursor vesicles arrive. This leaves open the question of how the vesicles interact with SpSpo13. It may be that other components of the SPB initially interact with the vesicles and this serves to recruit them for SpSpo13 action.

In vitro, the GEF activity of SpSpo13 is not strong relative to the GEF domain of ScSec2, even when assayed on SpYpt2. It may be that the GST-SpSpo13 fusion protein does not fold properly in vitro. Alternatively, other SPB proteins missing from the in vitro reactions may be necessary to stimulate greater GEF activity of SpSpo13 in vivo.

It should be noted that, in addition to SpSpo13, the *S. pombe* genome also contains an open reading frame (ORF) that seems to be a bona fide homologue of ScSec2, SPAC23C4.10. As with ScSec2, the predicted protein is large and contains an N-terminal GEF domain. Examination of other sequenced fungal genomes revealed the presence of two ScSec2/SpSpo13 related ORFs in many species. In the ascomycetes, such as *Aspergillus*, that contain both ORFs, one is shorter and more closely related to SpSpo13 and the other ORF is longer and more closely related to ScSec2. In the more distantly related basidiomycetes, such as *Coprinus* or *Cryptococcus*, one short and one long ORF are also present, although they are not obviously more closely related to SpSpo13 or ScSec2. Thus, in most fungi there seem to be two ScSec2/SpSpo13-related ORFs. However, in the Saccharomycotina, the lineage leading to budding yeasts, the shorter ORF has been lost and only the longer ScSec2-like ORF is present ([Figure 9](#F9){ref-type="fig"}; Supplemental Figure S1).

![Phylogenetic distribution of SpSpo13/ScSec2 related proteins within representative fungi. Fungal tree is based on [@B11]. Arrow indicates loss of an apparent SpSpo13 homologue in the Saccharomycotina lineage. Asterisks indicate that the two ORFs present in *Cryptococcus cinerus* and *Cryptococcus neoformans*, although one ORF is short and one ORF is long, do not obviously correspond to SpSpo13 and ScSec2, respectively.](zmk0071094010009){#F9}

Although no characterization of any of these genes has been reported, this observation raises the possibility that SPB-associated GEF activity is a conserved mechanism driving localized membrane formation during ascosporogenesis. In both *S. pombe* and *S. cerevisiae*, the MOP is essential for membrane formation. It is somewhat surprising therefore that there is no primary sequence homology between any of the *S. pombe* or *S. cerevisiae* MOP components so far identified. One interesting question is whether the *S. cerevisiae* MOP also contains a GEF activity, perhaps in a subunit structurally unrelated to SpSpo13/ScSec2. Alternatively, ScSec2 may provide the GEF activity at the MOP during *S. cerevisiae* meiosis. A temperature-sensitive *sec2* allele, *sec2-59*, sporulates well at restrictive temperature (Neiman, unpublished observations). However, this allele carries a stop codon that leaves the GEF domain intact ([@B25]; [@B46]). Testing the possible role of ScSec2 in sporulation in *S. cerevisiae* will require the isolation of an allele with conditional GEF activity.

The issue of how activation of ScSec4 leads to FSM precursor vesicle fusion remains to be determined. During exocytosis at the plasma membrane in *S. cerevisiae*, activated ScSec4 promotes fusion, in part, by mediating the interaction of the vesicle with the exocyst tethering complex ([@B13]). Presumably, SpYpt2 functions similarly in exocytosis in *S. pombe*. That activation of the SpYpt2 in FSM formation occurs in the context of a distinct tethering complex, the MOP, raises the question of whether or not the exocyst is required for coalescence of FSM precursor vesicles. If the MOP substitutes for the role of the exocyst in tethering the two membranes, then the Rab protein involved must promote fusion through some other route, perhaps by interaction with other factors that impinge on the assembly of SNARE complexes such as Sec1-family or tomosyn-family proteins ([@B1]; [@B47]; [@B12]).

Finally, these results highlight an intriguing parallel between FSM formation and ciliogenesis in animal cells. During ciliogenesis a membrane cap initially forms on one of the centrioles. This membrane expands as the centriole migrates to the cell periphery and will eventually fuse with the plasma membrane and form the sheath of the cilium ([@B43]). Transport to this ciliary membrane requires Rab8, a member of the same Rab subfamily as Sec4 ([@B24a]; [@B49]), and a centriole/basal body localized GEF, Rabin8, which is a Sec2/Spo13 family member ([@B24a]). Thus, in higher cells and in yeast, membrane organization by the microtubule organizing center uses orthologous Rabs and Rab-GEFs.
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FRET

:   fluorescence resonance energy transfer

FSM

:   forespore membrane

GEF

:   guanine nucleotide exchange factor

GST

:   glutathione transferase

MOP

:   meiosis II outer plaque

SPB

:   spindle pole body.

We thank Janet Leatherwood (Stony Brook University) for plasmid pJRU-MCS2, Gerry Smith and Chikashi Shimoda for *S. pombe* strains, Rolf Sternglanz (Stony Brook University) for anti-histidine antibody, and Nancy Hollingsworth for critical comments on the manuscript. We thank the Yeast Genetic Resource Center of Japan supported by the National BioResource Project (NBRP/YGRC) for plasmid FY532 and strain FY12476.
